EC Number | Cloned (Comment) | Organism |
---|---|---|
1.17.4.4 | coexpression of human coagulation factor (F)IX and c-myc-tagged VKORC1 mutant variants in HEK-293T cells in presence of varying warfarin concentrations | Homo sapiens |
1.17.4.4 | coexpression of human coagulation factor (F)IX andc-myc-tagged VKORC1 wild-type and mutants in HEK-293T cells in presence of varying warfarin concentrations | Homo sapiens |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
1.17.4.4 | L128R | site-directed mutagenesis, the mutant is resistant to warfarin and oral anti-coagulants | Homo sapiens |
1.17.4.4 | additional information | construction of warfarin-resistant VKORC1 variants following naturally occuring mutations in patients | Homo sapiens |
1.17.4.4 | V29L | site-directed mutagenesis, the mutant is resistant to warfarin and oral anti-coagulants | Homo sapiens |
1.17.4.4 | V45A | site-directed mutagenesis, the mutant is resistant to warfarin and oral anti-coagulants | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.17.4.4 | warfarin | mutants V29L, V45A, and L128R are resistant to inhibition by warfarin in vivo, oveview; VKORC1 function is measured in vitro using a dithiothreitol-driven vitamin K 2,3-epoxide reductase assay. Warfarin inhibits wild-type VKORC1 function by the DTTVKOR assay. However, VKORC1 variants with warfarin resistance-associated missense mutations often show low VKOR activities and warfarin sensitivity instead of resistance | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.17.4.4 | 2,3-epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone + 1,4-dithiothreitol + H2O | Homo sapiens | - |
2-methyl-3-phytyl-1,4-naphthoquinone + oxidized dithiothreitol | - |
? | |
1.17.4.4 | 2,3-epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone + 1,4-dithiothreitol + H2O | Homo sapiens | - |
2-methyl-3-phytyl-1,4-naphthoquinone + oxidized dithiothreitol | - |
r | |
1.17.4.4 | 2-methyl-3-phytyl-1,4-naphthoquinone + oxidized dithiothreitol + H2O | Homo sapiens | - |
2,3-epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone + 1,4-dithiothreitol | - |
? | |
1.17.4.4 | 2-methyl-3-phytyl-1,4-naphthoquinone + oxidized dithiothreitol + H2O | Homo sapiens | - |
2,3-epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone + 1,4-dithiothreitol | - |
r |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.17.4.4 | Homo sapiens | Q9BQB6 | - |
- |
1.17.4.4 | Homo sapiens | Q9BQB6 | mutants V29L, V45A, and L128R, oveview | - |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.17.4.4 | HEK-293T cell | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.17.4.4 | 2,3-epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone + 1,4-dithiothreitol + H2O | - |
Homo sapiens | 2-methyl-3-phytyl-1,4-naphthoquinone + oxidized dithiothreitol | - |
? | |
1.17.4.4 | 2,3-epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone + 1,4-dithiothreitol + H2O | - |
Homo sapiens | 2-methyl-3-phytyl-1,4-naphthoquinone + oxidized dithiothreitol | - |
r | |
1.17.4.4 | 2-methyl-3-phytyl-1,4-naphthoquinone + oxidized dithiothreitol + H2O | - |
Homo sapiens | 2,3-epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone + 1,4-dithiothreitol | - |
? | |
1.17.4.4 | 2-methyl-3-phytyl-1,4-naphthoquinone + oxidized dithiothreitol + H2O | - |
Homo sapiens | 2,3-epoxy-2,3-dihydro-2-methyl-3-phytyl-1,4-naphthoquinone + 1,4-dithiothreitol | - |
r |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.17.4.4 | vitamin K 2,3-epoxide reductase complex subunit 1 | - |
Homo sapiens |
1.17.4.4 | VKORC1 | - |
Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
1.17.4.4 | 7.4 | - |
assay at | Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
1.17.4.4 | additional information | - |
IC50 values for warfarin determined by different assay methods, overview | Homo sapiens | additional information | |
1.17.4.4 | 0.0000247 | - |
pH and temperature not specified in the publication | Homo sapiens | warfarin | |
1.17.4.4 | 0.000136 | - |
mutant V129L, pH and temperature not specified in the publication | Homo sapiens | warfarin | |
1.17.4.4 | 0.000152 | - |
mutant V145A, pH and temperature not specified in the publication | Homo sapiens | warfarin | |
1.17.4.4 | 0.001226 | - |
mutant L128R, pH and temperature not specified in the publication | Homo sapiens | warfarin |
EC Number | General Information | Comment | Organism |
---|---|---|---|
1.17.4.4 | additional information | VKORC1 function is measured in vitro using a dithiothreitol-driven vitamin K 2,3-epoxide reductase assay. Warfarin inhibits wild-type VKORC1 function by the DTT-VKOR assay. However, VKORC1 variants with warfarin resistance-associated missense mutations often show low VKOR activities and warfarin sensitivity instead of resistance. Development and evaluation of a cell culture-based, indirect VKOR assay accurately reports warfarin sensitivity or resistance for wild-type and variant VKORC1 proteins | Homo sapiens |
1.17.4.4 | additional information | VKORC1 function is measured in vitro using a dithiothreitol-driven vitamin K 2,3-epoxide reductase assay. Warfarin inhibits wild-type VKORC1 function by the DTTVKOR assay. However, VKORC1 variants with warfarin resistance-associated missense mutations often show low VKOR activities and warfarin sensitivity instead of resistance. Development and evaluation of a cell culture-based, indirect VKOR assay accurately reports warfarin sensitivity or resistance for wild-type and variant VKORC1 proteins | Homo sapiens |